Medication-induced hyperlipoproteinemia

Synonyms	N/A
Pronounce
Specialty	dermatology
Symptoms
Complications
Onset
Duration
Types
Causes
Risks
Diagnosis
Differential diagnosis
Prevention
Treatment
Medication
Prognosis
Frequency
Deaths

Medication-induced hyperlipoproteinemia is a condition that results from the decreasing of lipoprotein lipase activity resulting in eruptive xanthomas.<ref name="Andrews">,

 Andrews' Diseases of the Skin: clinical Dermatology, 
  
 Saunders Elsevier, 
 2006, 
  
  
 ISBN 978-0-7216-2921-6,</ref> 

See also

• Normolipoproteinemic xanthomatosis
• Cerebrotendinous xanthomatosis
• Skin lesion

References

   This article is a cutaneous condition stub. You can help WikiMD by expanding it!

   This article is a medical stub. You can help WikiMD by expanding it!